Our top pick for
Apollo Medical Holdings, Inc is a medical care facilities business based in the US. Apollo Medical shares (AMEH) are listed on the NASDAQ and all prices are listed in US Dollars. Apollo Medical employs 547 staff and has a trailing 12-month revenue of around USD$689.1 million.
|Latest market close||USD$17.99|
|52-week range||USD$9.27 - USD$19.5|
|50-day moving average||USD$18.0071|
|200-day moving average||USD$17.4598|
|Wall St. target price||USD$30|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.961|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||-17.93%|
|1 month (2020-12-17)||-0.17%|
|3 months (2020-10-16)||-1.59%|
|6 months (2020-07-16)||7.40%|
|1 year (2020-01-16)||-3.07%|
|2 years (2019-01-16)||-5.07%|
|3 years (2018-01-16)||29|
|5 years (2016-01-13)||227.09%|
Valuing Apollo Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Apollo Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Apollo Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Apollo Medical shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Apollo Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$84 million.
The EBITDA is a measure of a Apollo Medical's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$689.1 million|
|Operating margin TTM||9.51%|
|Gross profit TTM||USD$92.8 million|
|Return on assets TTM||5.24%|
|Return on equity TTM||27.15%|
|Market capitalisation||USD$643.1 million|
TTM: trailing 12 months
There are currently 315,737 Apollo Medical shares held short by investors – that's known as Apollo Medical's "short interest". This figure is 9.7% up from 287,688 last month.
There are a few different ways that this level of interest in shorting Apollo Medical shares can be evaluated.
Apollo Medical's "short interest ratio" (SIR) is the quantity of Apollo Medical shares currently shorted divided by the average quantity of Apollo Medical shares traded daily (recently around 69699.116997792). Apollo Medical's SIR currently stands at 4.53. In other words for every 100,000 Apollo Medical shares traded daily on the market, roughly 4530 shares are currently held short.
However Apollo Medical's short interest can also be evaluated against the total number of Apollo Medical shares, or, against the total number of tradable Apollo Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Apollo Medical's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Apollo Medical shares in existence, roughly 10 shares are currently held short) or 0.0227% of the tradable shares (for every 100,000 tradable Apollo Medical shares, roughly 23 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Apollo Medical.
Find out more about how you can short Apollo Medical stock.
We're not expecting Apollo Medical to pay a dividend over the next 12 months.
Apollo Medical's shares were split on a 1:10 basis on 27 April 2015. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Apollo Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Apollo Medical shares which in turn could have impacted Apollo Medical's share price.
Over the last 12 months, Apollo Medical's shares have ranged in value from as little as $9.27 up to $19.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Apollo Medical's is 0.4925. This would suggest that Apollo Medical's shares are less volatile than average (for this exchange).
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver quality care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It caters to patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. Apollo Medical Holdings, Inc. was founded in 1994 and is headquartered in Alhambra, California.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.